Low Dose Aspirin (LDA) To Prevent Preeclampsia: A Case Report |Biomedgrid
Journal: American Journal of Biomedical Science & Research (Vol.14, No. 5)Publication Date: 2021-10-28
Authors : Andhika Ardi Perdana; E Anita Syara; Eka Rusdianto Gunardi; Yogi Pasidri;
Page : 425-428
Keywords : Gestational hypertension; Preeclampsia; Low-dose aspirin; Morbidity; Mortality;
Abstract
Introduction: Gestational hypertension affects the majority of pregnant women in the world. Gestational hypertension is blood pressure >140/90 mmHg on two examinations with a distance at 4 hours after 20 weeks of gestation, at previously normal blood pressure. ACOG recommendation for low-dose aspirin (LDA) in women (81 mg/day) at high risk of preeclampsia. Low-dose aspirin is generally considered safe during pregnancy. Low-dose aspirin (LDA) can prevent vascular disorders in pregnancy, such as preeclampsia, stillbirth preterm labor, intrauterine growth restriction (IUGR), and early miscarriage.
Other Latest Articles
- Synthetic DNA (Human Placenta) Crown Cells Elongate Bacillus Subtilis-Elongation Occurs with the Combination of Sphingosine and DNA |Biomedgrid
- Analysis of the Variation in Corneal Parameters with regard to Refractive Error in Saudi Arabian Adults |Biomedgrid
- Altering Trichomonas Vaginalis Codons Enhances Expression of The Trichomonad P270 Repeat Element in Escherichia Coli |Biomedgrid
- The Importance of Early Treatment of COVID-19 |Biomedgrid
- Transactional Leadership |Biomedgrid
Last modified: 2023-11-08 21:50:01